Related Experiment Video
Updated: Jul 19, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
SUOH 03 Guidewire for the Management of Coronary Artery Dissection: Insights from a Multicenter Registry
Gabriele L Gasparini1, Mario Bollati2, Mauro Chiarito1,3
1IRCCS Humanitas Research Hospital, Rozzano, Italy.
Background:
In the setting of coronary artery dissection, both spontaneous and iatrogenic, fixing the intimal tear, usually with stent implantation, can be extremely challenging if the distal wire position has been lost. Common complications are mainly related to the inadvertent subintimal tracking of the guidewire while attempting to gain the distal true lumen.
Aims:
To report the registry results of using the SUOH 0.3 guidewire for managing coronary artery dissection in a real-world multicenter setting.
Methods:
The study population in this retrospective, multicenter, international registry included 75 consecutive patients who underwent PCI and required an antegrade wiring of a dissected coronary artery.
Results:
Successful use of SUOH 0.3 was achieved in 69 (92%) patients. The use of a microcatheter was associated with a significantly higher rate of TIMI 3 flow at the end of the procedure (no microcatheter: n = 17, 81%; microcatheter: n = 52, 96.3%; p = 0.017). The first recanalization attempt was made with the SUOH 03 guidewire in 48 (64%) cases, and it was successful in 42 (87%). The overall PCI success rate was reported in 72 (96%) patients, with no significant differences among patients with different origins, mechanisms, and locations of dissection.
Conclusions:
In this setting, the SUOH 0.3 guidewire provides high procedural success without additional complex techniques.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management

